Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Prandin introduced for treatment of type II diabetes in U.S.

June 3, 1998

Novartis files for U.S. marketing approval of Sandostatin LAR

June 3, 1998

New Lilly compounds for postmenopausal syndrome

June 3, 1998

Inhibitors of cysteine protease from SKB for bone and cartilage disorders

June 3, 1998

Patient enrollment complete for RII retinamide phase I/II trial

June 3, 1998

Research demonstrates vital role of hMSCs in hematopoiesis

June 2, 1998

Potent new cholesterol biosynthesis inhibitors reported by Novartis

June 2, 1998

Theratechnologies' GRF analogues receive patent coverage

June 2, 1998

SR-146131, the most potent CCK-A receptor agonist reported to date

June 2, 1998

Novartis and Trega sign agreement for obesity and diabetes research

June 1, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 26, 2026
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...